1887

Abstract

SUMMARY

To understand the complete immunochemical structure of the Epstein-Barr virus (EBV) major membrane glycoprotein gp350/220, monoclonal antibodies (MAbs) reacting with this important viral antigen were isolated. Through competitive inhibition binding studies, it was determined that a group of 18 IgG MAbs recognized seven distinct epitopes on the gp350/220 molecule. Eight of these MAbs fell into a single epitope group with four of those MAbs, as well as a single MAb from another epitope group, being capable of neutralizing EBV strain B95–8 transformation of umbilical cord lymphocytes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-2-535
1987-02-01
2021-10-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/2/JV0680020535.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-2-535&mimeType=html&fmt=ahah

References

  1. Beisel c., Tann j., Matsuo T., Thorley-Lawson D., Kezdy F., Kieff E. 1985; Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene. Journal of Virology 54:665–674
    [Google Scholar]
  2. Black F. L., Woodall J. P., Evans A. J., Liebhaber H., Henle G. 1970; Prevalence of antibody against viruses in the Tiriyo an isolated Amazon tribe. American Journal of Epidemiology 91:430–438
    [Google Scholar]
  3. Boyum A. 1968; Separation of leukocytes from blood and bone marrow. Scandinavian Journal of Clinical Laboratory Investigation 21: Suppl. 97 51
    [Google Scholar]
  4. De The G. 1982; Epidemiology of Epstein-Barr virus and associated diseases in man. In The herpesviruses pp. 25–104 Roizman B. Edited by New York: Plenum Press;
    [Google Scholar]
  5. Greenwood F. S., Hunter W. M., Glover J. S. 1963; The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochemical Journal 89:114–123
    [Google Scholar]
  6. Henle G., Henle W. 1979; The virus as the etiologic agent of infectious mononucleosis. In The Epstein-Barr virus pp. 297–320 Epstein M., Achong B. Edited by New York: Springer-Verlag;
    [Google Scholar]
  7. Hoffman G., Lazarowitz S., Hayward S. D. 1980; Monoclonal antibody against a 250,000 dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proceedings of the National Academy of Sciences, U.S.A 772979–2983
    [Google Scholar]
  8. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
  9. Lange D. J., Garruto R. M., Gajdusek D. C. 1977; Early acquisition of cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations. American Journal of Epidemiology 105:480–487
    [Google Scholar]
  10. Lemke H., Hämmerling G. J. 1982; Clustering of antigenic determinants on H-2 molecules. Journal of Immunology 128:2465–2469
    [Google Scholar]
  11. Parham P., Androlewicz M. J., Brodsky F. M., Holmes N. J., Ways J. P. 1982; Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. Journal of Immunological Methods 53:133–173
    [Google Scholar]
  12. Purtilo D., Sakamoto K., Saemundson A., Sullivan J., Sunnersholm A., Anvret M., Pritchard J., Sloper C., Sieff C., Pincott J., Pachman L., Rich K., Cruze F., Cornet J., Collins R., Barnes N., Knight J., Sandstadt B., Klein G. 1981; Documentation of EBV infection in immunodeficient patients with life threatening lymphoproliferative diseases by clinical virological and immunopathological studies. Cancer Research 41:4226–4236
    [Google Scholar]
  13. Qualtiere L. F., Pearson G. R. 1979; Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. International Journal of Cancer 23:808–814
    [Google Scholar]
  14. Qualtiere L., Pearson G. 1980; Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B95-8- virus-transformed producer culture activated with tumor-promoting agents (TPA). Virology 102:360–369
    [Google Scholar]
  15. Qualtiere L. F., Chase R., Pearson G. R. 1982a; Purification and biologic characterization of a major Epstein-Barr virus-induced membrane glycoprotein. Journal of Immunogy 129:814–818
    [Google Scholar]
  16. Qualtiere L., Chase R., Vroman B., Pearson G. 1982b; Identification of Epstein-Barr virus strain differences with monoclonal antibody to membrane antigen. Proceedings of the National Academy of Sciences, U.S.A 79616–620
    [Google Scholar]
  17. Staehelin T., Hobbs D. S., Kung H., Lai c., Pestka S. 1981; Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. Journal of Biological Chemistry 256:9750–9754
    [Google Scholar]
  18. The T. H., Feltkamp T. E. W. 1970; Conjugation of fluorescein isothiocyanate to antibodies. Immunology 18:865–881
    [Google Scholar]
  19. Thorley-Lawson D. A., Geilinger K. 1980; Monoclonal antibodies against the major (gp350-220) of Epstein-Barr virus neutralize infectivity. Proceedings of the National Academy of Sciences, U.S.A 775307–5311
    [Google Scholar]
  20. Thorley-Lawson D. A., Poodry C. A. 1982; Identification and isolation of the main component (gp350/gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. Journal of Virology 43:730–736
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-2-535
Loading
/content/journal/jgv/10.1099/0022-1317-68-2-535
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error